SOAT1 and systemic lupus erythematosus: Given the positive local genetic correlation between CD/UC with SLE in the region harboring the JAK2 variant, patients with comorbid CD/UC and SLE may uniquely benefit from therapeutics targeting the JAK-STAT pathway, though this requires further study and investigation.